Although generally considered as rare, incidence of gastrointestinal neuroendocrine tumors (GI-NETs) is increasing. The general practitioner has thus to be familiar with the vast array of clinical presentations and the growing family of diagnostic tools that can be used. Symptoms can be related to their hormonal production, their local extent or a bleeding complication. The prognosis depends on the grade of tumor, its local extent at diagnosis and its localization. The diagnosis relies on radiologic, endoscopic and nuclear medicine strategies. In case of typical symptoms, a hormonal secretion should be sought. Treatment options are extensive and should be discussed in an interdisciplinary manner
AbstractGastric neuroendocrine tumors (NETs) are rare and can occur in patients with chronic atrophi...
Neuroendokrini tumori (NET - engl. Neuroendocrine tumors) gastrointestinalnog (GI - engl. Gastrointe...
While the incidence rate of neuroendocrine tumours has been increasing, the survival rate has not. T...
Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms that present ma...
Gastroenteropancreatic (GEP) neuroendocrine tumours (NETS) are fairly rare neoplasms that present ma...
Neuroendocrine tumours of the digestive system (GEP-NET) are relatively rare. Nevertheless, their di...
Abstract Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are relatively rare and complex neo...
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) represent a heterogeneous group of tumors...
Objectives. The gastrointestinal neuroendocrin tumors are rare events with clinical presentation wid...
Gastroenteropancreatic neuroendocrine tumours (GEP- nETs) are rare neoplasms with a complex spectrum...
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are rare neoplasms. They are varied in the...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endoc...
Gastro-entero-pancreatic neuroendocrine tumours (GEP NET) represent a rare and highly heterogeneous ...
Neuroendocrine tumors (NETs) originate from single or clustered neuroendocrine cells, distributed in...
AbstractGastric neuroendocrine tumors (NETs) are rare and can occur in patients with chronic atrophi...
Neuroendokrini tumori (NET - engl. Neuroendocrine tumors) gastrointestinalnog (GI - engl. Gastrointe...
While the incidence rate of neuroendocrine tumours has been increasing, the survival rate has not. T...
Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms that present ma...
Gastroenteropancreatic (GEP) neuroendocrine tumours (NETS) are fairly rare neoplasms that present ma...
Neuroendocrine tumours of the digestive system (GEP-NET) are relatively rare. Nevertheless, their di...
Abstract Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are relatively rare and complex neo...
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) represent a heterogeneous group of tumors...
Objectives. The gastrointestinal neuroendocrin tumors are rare events with clinical presentation wid...
Gastroenteropancreatic neuroendocrine tumours (GEP- nETs) are rare neoplasms with a complex spectrum...
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are rare neoplasms. They are varied in the...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endoc...
Gastro-entero-pancreatic neuroendocrine tumours (GEP NET) represent a rare and highly heterogeneous ...
Neuroendocrine tumors (NETs) originate from single or clustered neuroendocrine cells, distributed in...
AbstractGastric neuroendocrine tumors (NETs) are rare and can occur in patients with chronic atrophi...
Neuroendokrini tumori (NET - engl. Neuroendocrine tumors) gastrointestinalnog (GI - engl. Gastrointe...
While the incidence rate of neuroendocrine tumours has been increasing, the survival rate has not. T...